Glioblastomas and hepatocellular carcinomas with high metabolic stress adapt by upregulating DHODH, and inhibition of this enzyme restores sensitivity to chemotherapeutics such as temozolomide and platinum drugs [14,21,68]. This evidence concerns the gene DHODH and hepatocellular carcinoma.